Progyny sees FY26 adjusted EPS $1.83-$1.95, consensus $1.96

Sees FY26 revenue $1.36B-$1.41B, consensus $1.39B. Sees FY26 adjusted EBITDA $224M-$239M. “As the first quarter begins, member activity continues to remain healthy. Even so, the 2026 guidance ranges we are issuing today reflect the potential for variability in member engagement, which is consistent with the approach we’ve been following for well over a year,” said Anevski.